BostonGene, developer of the leading AI foundation model for cancer and the immune system, today announced seven abstracts have been accepted for presentation at the San Antonio Breast Cancer ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, and Biogen Inc. today announced data presentations ...

Experiment 2: Collect and analyze soil samples from two different sites, studying texture, moisture content, pH, and water-holding capacity, and relating these factors to the types of plants found.

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

Scientists have recovered ancient RNA from a 39,000-year-old woolly mammoth in Siberia, offering an unprecedented glimpse into its biology. Preserved by permafrost, the RNA reveals gene activity ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

During the quarter, we settled our worldwide patent litigation with Bruker on favorable terms and recognized an upfront ...